Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population

被引:3
|
作者
Kumar, Pratyush [1 ,4 ]
Rawat, Sonia [2 ]
Kakar, Atul [3 ]
Sinha, Abhay K. [1 ]
机构
[1] Patna Med Coll & Hosp, Dept Geriatr, Patna, Bihar, India
[2] EHC, Delhi, India
[3] Sir Ganga Ram Hosp, Dept Med, New Delhi, India
[4] Patna Med Coll Hosp PMCH, Dept Geriatr, Patna 800004, Bihar, India
关键词
Diabetes; fatty liver; NAFLD; prediabetes; EPIDEMIOLOGY; INDIA;
D O I
10.4103/jfmpc.jfmpc_856_22
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a global emerging health issue, which is due to extra fat deposition in the liver that poses a serious risk of liver cirrhosis. Our study assessed the glycaemic status and NAFLD in health patients coming for a regular health check-ups. Material and Methods: This descriptive study was done on 192 healthy populations aged 30-70 years who underwent general health check-ups. History, clinical examination, heamtological and radiological workup were done and data were statistically evaluated. Results: The age of the study population was between 30 and 70 years with an average age of 50 years and the study sample size was 190. Prevalence of prediabetes was 35.93%, diabetes at 17.18% and euglycaemics were 45.83% in our study group. Among diabetics and prediabetics, 30% and 31% were having raised transaminase. Among euglycaemics, around 19% had raised transaminase. On ultrasound scans among the diabetic group, the prevalence of fatty liver was 57.6% whereas in the prediabetic group it was 46.4%. Among the normal euglycaemic group, 22.7% had fatty liver. Conclusion: NAFLD is multifactorial and associated with diabetes and can progress to cirrhosis of the liver if untreated. There is a need to have more focus on screening, awareness, nutritional counselling and treatment at the primary care level.
引用
收藏
页码:7640 / 7643
页数:4
相关论文
共 50 条
  • [31] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [32] New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
    Andrade, Antonio R.
    Bittencourt, Paulo L.
    Codes, Liana
    Evangelista, Maria A.
    Castro, Alessandra O.
    Sorte, Ney Boa
    Almeida, Carolina G.
    Bastos, Jorge A.
    Cotrim, Helma P.
    ANNALS OF HEPATOLOGY, 2017, 16 (06) : 932 - 940
  • [33] Cardiovascular risk factors in non-alcoholic fatty liver disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Askling, Johan
    Hultcrantz, Rolf
    Kechagias, Stergios
    LIVER INTERNATIONAL, 2019, 39 (01) : 197 - 204
  • [34] Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina
    Villamil, Federico Guillermo
    Barbero, Manuel
    Massenzio, Nancy Elena
    Giani, Sandra Monica
    Kozima, Shigeru
    Cairo, Fernando Mario
    Belloni, Rodrigo Agustin
    Mariani, Javier
    Gazari, Mercedes Rodriguez
    Coisson, Paola Evangelina
    Gallardo, Sonia Carolina
    Cocco, Paula Andrea
    Riboldi, Claudia Mabel
    Gallardo, Patricia Eugenia
    ANNALS OF HEPATOLOGY, 2023, 28 (04)
  • [35] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [36] Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease
    Yilmaz, Yusuf
    Senates, Ebubekir
    Yesil, Atakan
    Ergelen, Rabia
    Colak, Yasar
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (03) : 328 - 331
  • [37] Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus
    Weinstein, Ali A.
    de Avila, Leyla
    Paik, James
    Golabi, Pegah
    Escheik, Carey
    Gerber, Lynn
    Younossi, Zobair M.
    PSYCHOSOMATICS, 2018, 59 (06) : 567 - 574
  • [38] Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions
    Cusi, Kenneth
    DIABETOLOGIA, 2016, 59 (06) : 1112 - 1120
  • [39] Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology (vol 13, 1031633, 2022)
    Memaj, P.
    Jornayvaz, F. R.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [40] Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia
    Chan, Wah-Kheong
    Tan, Alexander Tong-Boon
    Vethakkan, Shireene Ratna
    Tah, Pei-Chien
    Vijayananthan, Anushya
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (08) : 1375 - 1383